Abstract
No translate
No translate
No translate
No translate
Phan Tuấn Đạt; Phạm Mạnh Hùng
References
1.
1. AboyansV.,RiccoJ.B.,BartelinkM.E.L.,etal.(2018), "2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)", Eur Heart J, 39 (9), pp. 763-816.
2.
2. BeckmanJ.A.(2002), "Diabetes and Atherosclerosis: Epidemiology, Pathology and Management.
3.
3. Beckman J. A., Creager M. A., Libby P. (2002), "Diabetes and atherosclerosis: epidemiology, pathophysiology, and management", JAMA, 287 (19), pp. 2570-81
4.
4. Cefalu W. T. (2017), "Standards of Medical Care in Diabetes 2017", AMERICAN DIABETES ASSOCIATION 40, pp. 13-14.
5.
5. Cho S. W., Kim B. G., Kim D. H., et al. (2015), "Prediction of coronary artery disease in patients with lower extremity peripheral artery disease", International heart journal, 56 (2), pp. 209-212.
6.
6. CouncilE.S.,RedonJ.,NarkiewiczK.,etal.(2013), "2013 ESH/ESC Guidelines for the management of arterial hypertension", European Heart Journal, 34, pp. 2159-2219.
7.
7. DuranNE,DuranI,GürelE,etal.Coronary artery disease in patients with peripheral artery disease. Heart Lung 2010; 39: 116-20.
8.
8. FowkesF. G.R., RudanD., RudanI., etal. (2013), "Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis", The Lancet, 382 (9901), pp. 1329-1340.
9.
9. GensiniGG.(1983)“A more meaningful scoring system for determining the severity of coronary heart disease”. Am J Cardiol, 51:606
10.
10. Her K., Choi C., Park Y., et al. (2008), "Concomitant peripheral artery disease and asymptomatic coronary artery disease: a management strategy", Annals of vascular surgery, 22 (5), pp. 649-656.
11.
11. Hertzer N. R. (1987), "Basic data concerning associated coronary disease in peripheral vascular patients", Ann. Vasc. Surg., 1, pp. 616-620.
12.
12. Marsico F., Ruggiero D., Parente A., et al. (2013), "Prevalence and severity of asymptomatic coronary and carotid artery disease in patients with lower limbs arterial disease", Atherosclerosis, 228 (2), pp. 386- 389.
13.
13. Mohaghegh A Mohebi M, Kamal Hedayat D, Tabatabaee A, Naseri N, (2011), “The relationship of Gensini score with the cardiovascular risk of patients with indication of angiography” Tehran Univ Med J. 2011; 69 (6) :388-392
14.
14. Perrone-FilardiP.,CuocoloA.,BrevettiG.,etal.(2005), "Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease", American Journal of Cardiology, 96 (9), pp. 1337-1341.
15.
15. PranabJyotiBhattacharyya,SharatVijapur,AnjanKumarBhattacharyya(2016), “A Study of cardiovascular risk factors correlation with the angiographic severity of coronary artery disease using Syntax score”, Journal of Dental and Medical Sciences, Volume 15, Issue 1 Ver. IV ( Jan. 2016), PP 21-28.
16.
16. PrescottE.,HippeM.,SchnohrP.,etal.(1998), "Smoking and risk of myocardial infarction in women and men: longitudinal population study", BMJ, 316 (7137), pp. 1043-7.
17.
17. ProgramN.C.E.(2002), "Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106 (25).
18.
18. R.E.(2004), "The problem of tobacco smoking", BMJ, 328, pp. 217-219.
19.
19. RipaR.S.,KjaerA.,HesseB.(2014), "Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease", Current atherosclerosis reports, 16 (6), pp. 415.
20.
20. SatirogluO.,KocamanS.A.,KaradagZ.,etal.(2012), "Relationship of the angiographic extent of peripheral arterial disease with coronary artery involvement", JPMA-Journal of the Pakistan Medical Association, 62 (7), pp. 644.
21.
21. SukhijaR.,YalamanchiliK.,AronowW.S.(2003), "Prevalence of left main coronary artery disease, of three-or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease", American Journal of Cardiology, 92 (3), pp. 304-305
22.
22. TheCOMMITResearchGroup(1995),"CommunityInterventionTrialforSmokingCessation(COMMIT): I. cohort results from a four-year community intervention", Am J Public Health, 85 (2), pp. 183-92.
23.
23. Yilmaz MB, Guray Y, Guray U, Biyikoglu SF, Tandogan I, Korkmaz S., (2006), “Metabolic syndrome increases the risk of signifcant coronary artery involvement in patients with peripheral artery disease”, Coron Artery Dis, 17, pp. 529-32
24.
Mời Quý vị download Số Tạp chí tại đây: Download file pdf
Tác giả
Nguyễn Phước Lộc: Bệnh viện Nguyễn Trãi, TP. Hồ Chí Minh;
Trương Quang Bình: Bệnh viện Đại học Y Dược TP. Hồ Chí Minh;
Files
Article Views318
Document Views0
Downloads7
Section
NGHIÊN CỨU LÂM SÀNG
Issue
Số 91+92, 2021
Category
BỆNH MẠCH VÀNH
Pages
25-34
Copyright Holder
2020 Tạp chí Tim mạch học Việt Nam